Prostate Cancer - Results from #100

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer. January 6, 2025

Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancer. January 6, 2025

MRI-based Radiomics for Predicting Prostate Cancer Grade Groups: A Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies. January 3, 2025

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study. January 3, 2025

Prospective per-target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets. January 3, 2025

Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial. January 3, 2025

Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis-a systematic review including meta-analysis of all comparative studies. January 3, 2025

Challenges of Urologic Oncology in Low-to-Middle-Income Countries January 2, 2025

Urologic Cancer Drug Costs in Low- and Middle-Income Countries January 2, 2025

Life expectancy in rare histological prostate cancer subtypes. January 2, 2025

Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative. January 2, 2025

The PROCAN-B study protocol: Early diagnosis of PROstate CANcer for Black men-a community-centred participatory approach in Scotland and the North-East of England. January 2, 2025

The 340B Drug Pricing Program and Management of Advanced Prostate Cancer. January 2, 2025

Functional outcomes of single-session holmium laser enucleation of the prostate and high-intensity focused ultrasound in management of patients with prostate cancer and enlarged prostate: results from a pilot study. January 2, 2025

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. January 1, 2025

Prostate-specific antigen testing in the United States during 2008-2022 in relation to the US preventive services task force recommendations. January 1, 2025

A controlled study of use and effectiveness of phosphodiesterase-5 inhibitors in long-term survivors after curative radiotherapy for prostate cancer (PCa). January 1, 2025

Grading the Evidence for Physical Activity and any Outcome in Cancer Survivors: an Umbrella Review of 740 Meta-analytic associations. January 1, 2025

Functional and Oncological Outcomes of Very Large Prostate Sizes Post Robotic Radical Prostatectomy: A Propensity Score-Matched Analysis. January 1, 2025

Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology Practices. December 31, 2024

Page 6 of 1454